Bliss Kelly's Form 4/A amendment
AmendedTeladoc Health, Inc. (TDOC) · filed Mar 12, 2026
- Accession no.
- 0002036989-26-000004
- Filed
- Mar 12, 2026
- Trade date
- Feb 27, 2026
- Filing delay
- 13 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 3, 2026
This filing lists 2 derivative transactions. It carries over 11 transactions from the original filing that it did not restate. Open-market sales total $136.4K. It was filed 13 days after the trade.
This amendment restates part of 0002036989-26-000002 (filed Mar 3, 2026). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bliss KellyCIK 0002036989 | Officer (President, U.S. Group Health) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | AGrant or awardAcquired | +15,596 | $0.00 | $0 | 15,596 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −5,198 | $0.00 | $0 | 10,398 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0002036989-26-000002 (filed Mar 3, 2026).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +3,488 | –F1 | – | 63,542 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +4,858 | –F1 | – | 68,400 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +36,610 | –F1 | – | 105,010 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +1,186 | –F2 | – | 106,196 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +5,198 | –F2 | – | 111,394 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −26,647 | $5.12 | −$136,432.64 | 84,747 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −3,488 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −4,858 | $0.00 | $0 | 19,435 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −36,610 | $0.00 | $0 | 73,222 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −1,186 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2026 | Common Stock | AGrant or awardAcquired | +181,661 | $0.00 | $0 | 181,661 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F2
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 2 transactions in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- F2
Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
- F3
The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- F4
The Form 4 filed March 3, 2026, inadvertently included an incorrect amount for the number of performance stock units awarded. This amendment reports the correct amount.
- F5
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- F6
On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.